Teen Talk High School Refresher Rigorous Evaluation
Launched by ETR ASSOCIATES · Aug 26, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background Unintended pregnancy rates among teenagers are higher in rural counties than urban or suburban counties. The Teen Talk High School Refresher (TTHSR) is a sexual health education (SHE) "booster" program for older high school students attending school in rural communities that was designed to help address this. Though there is preliminary evidence of the program's effectiveness, it has not yet been rigorously evaluated. With this study, ETR will rigorously evaluate the effectiveness of TTHSR with a randomized controlled trial.
TTHSR is designed to equip 11th and 12th grade student...
Gender
ALL
Eligibility criteria
- • Since the study is a cluster RCT, we will identify partner schools before determining eligibility at the individual student level. Each school will participate for 2 years and be randomly assigned to an "intervention first" or "control first" arm. Schools will select a class or other group comprising mostly or solely 11th and 12th graders (e.g., a science class, the 11th grade annual retreat) for us to carry out the study with, and commit to providing a similar class or group for participation in their second year of the study.
- Inclusion Criteria:
- • part of the class or group identified by their school
- • 16 to 19 years old
- • sufficient English language skills (as assessed by data collector) to take part in the TTHSR intervention
- Exclusion Criteria:
- • Under 16 years old
- • 20 years old or over
- • Insufficient English language skills (as assessed by data collector) to take part in the TTHSR intervention
About Etr Associates
ETR Associates is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient outcomes. With a strong emphasis on innovation and collaboration, ETR Associates specializes in designing and executing clinical trials across various therapeutic areas. Their experienced team of professionals is committed to maintaining the highest ethical standards and regulatory compliance, ensuring that each study is conducted with integrity and rigor. By leveraging cutting-edge methodologies and fostering partnerships with healthcare providers, ETR Associates aims to contribute valuable insights to the medical community and enhance the development of new therapeutics.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Scotts Valley, California, United States
Patients applied
Trial Officials
Pamela J Drake, PhD
Principal Investigator
ETR Associates
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported